Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PRKX Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA527913
Description
Recommended positive controls: 293T, A431, mouse brain. Predicted reactivity: Mouse (88%), Rat (88%), Rhesus Monkey (99%), Chimpanzee (95%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
PRKX is a serine/threonine kinase related to the catalytic subunit of the cAMP-dependent protein kinases. PRKX is developmentally regulated and may be involved in renal epithelial morphogenesis. This protein may also be involved in macrophage and granulocyte maturation. Abnormal recombination between this gene and a related pseudogene on chromosome Y is a frequent cause of sex reversal disorder in XX males and XY females. Pseudogenes of this gene are found on chromosomes X, 15 and Y.
Specifications
PRKX | |
Polyclonal | |
Unconjugated | |
PRKX | |
cAMP-dependent protein kinase catalytic subunit PRKX; Pkare; PKA-related protein kinase; PKX1; PrKX; Protein kinase PKX1; protein kinase X; protein kinase X-linked; protein kinase, X-linked; putative serine/threonine kinase; serine/threonine-protein kinase PRKX | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
19108, 5613 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.54 mg/mL | |
0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7 | |
P51817, Q922R0 | |
PRKX | |
Recombinant fragment corresponding to a region within amino acids 44 and 309 of Human PRKX. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction